Thus, the pleiotropic physiological effects of PPARα activity in the CNS suggest a potential protective role of PPARα agonists in neuropsychiatric disorders and neurodegenerative diseases, and this system has become a relevant topic for basic and clinical research as a novel therapeutic strategy for the treatment of diverse CNS pathological conditions. The gene discussed is PPARA; the disease is neurodegenerative disease.